PMC:7696151 / 10957-11158 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"303","span":{"begin":75,"end":83},"obj":"Species"},{"id":"324","span":{"begin":140,"end":143},"obj":"Chemical"},{"id":"325","span":{"begin":167,"end":170},"obj":"Chemical"},{"id":"337","span":{"begin":47,"end":61},"obj":"Disease"}],"attributes":[{"id":"A303","pred":"tao:has_database_id","subj":"303","obj":"Tax:9606"},{"id":"A324","pred":"tao:has_database_id","subj":"324","obj":"MESH:D006886"},{"id":"A325","pred":"tao:has_database_id","subj":"325","obj":"MESH:D015215"},{"id":"A337","pred":"tao:has_database_id","subj":"337","obj":"MESH:D015658"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"cebo-controlled clinical trial conducted on 72 HIV-l-infected asymptomatic patients. All subjects were treated for 16 weeks with 800 mg/day HCQ (n = 35) or 500 mg/day ZDV (n = 37). As in the previous s"}

{"project":"LitCovid-sentences","denotations":[{"id":"T91","span":{"begin":85,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"cebo-controlled clinical trial conducted on 72 HIV-l-infected asymptomatic patients. All subjects were treated for 16 weeks with 800 mg/day HCQ (n = 35) or 500 mg/day ZDV (n = 37). As in the previous s"}